Liu TS - Search Results

1

Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer.

Ma GF, Zhang HG, Liu J, Chen YX, Xiao H, Wang XF, He J, Zeng ZC, Sun J, Liu TS. Ma GF, et al. Among authors: liu j, liu ts. Cancer Manag Res. 2019 Jul 2;11:6029-6041. doi: 10.2147/CMAR.S204887. eCollection 2019. Cancer Manag Res. 2019. PMID: 31303797 Free PMC article.

2

[Clinical values of extended lymph node dissection for gastric cancer:a meta-analysis for D1 versus D2 gastrectomy].

Wang XF, Sun YH, Liang DJ, Wang C, Fang Y, Liu TS, Qin XY. Wang XF, et al. Among authors: liu ts. Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Sep;10(5):425-30. Zhonghua Wei Chang Wai Ke Za Zhi. 2007. PMID: 17851781 Chinese.

3

Consideration of the role of radiotherapy for abdominal lymph node metastases in patients with recurrent gastric cancer.

Sun J, Sun YH, Zeng ZC, Qin XY, Zeng MS, Chen B, Liu TS, Zhang JY. Sun J, et al. Among authors: liu ts. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):384-91. doi: 10.1016/j.ijrobp.2009.05.019. Epub 2009 Jul 4. Int J Radiat Oncol Biol Phys. 2010. PMID: 19577861

4

[Adjuvant chemotherapy for gastric cancer: more drugs do not mean better efficacy].

Li W, Liu TS, Sun YH, Shen KT, Shen ZB, Wang ZM, Cui YH, Yu YY. Li W, et al. Among authors: liu ts. Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Jun;14(6):432-5. Zhonghua Wei Chang Wai Ke Za Zhi. 2011. PMID: 21713703 Chinese.

5

A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.

Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y, Sun YH, Shen KT, Shen ZB, Qin XY, Liu TS. Wang Y, et al. Among authors: liu ts. Cancer Chemother Pharmacol. 2014 Jun;73(6):1155-61. doi: 10.1007/s00280-014-2449-1. Epub 2014 Apr 21. Cancer Chemother Pharmacol. 2014. PMID: 24748418 Free PMC article. Clinical Trial.

6

Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.

Wang Y, Cheng X, Cui YH, Hou J, Ji Y, Sun YH, Shen ZB, Liu FL, Liu TS. Wang Y, et al. Among authors: liu fl, liu ts. BMC Cancer. 2018 Jun 28;18(1):702. doi: 10.1186/s12885-018-4615-z. BMC Cancer. 2018. PMID: 29954358 Free PMC article.

7

Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).

Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, Han GH, Wang MQ, Liu RB, Lu LG, Ren ZG, Chen MS, Zeng ZC, Liang P, Liang CH, Chen M, Yan FH, Wang WP, Ji Y, Cheng WW, Dai CL, Jia WD, Li YM, Li YX, Liang J, Liu TS, Lv GY, Mao YL, Ren WX, Shi HC, Wang WT, Wang XY, Xing BC, Xu JM, Yang JY, Yang YF, Ye SL, Yin ZY, Zhang BH, Zhang SJ, Zhou WP, Zhu JY, Liu R, Shi YH, Xiao YS, Dai Z, Teng GJ, Cai JQ, Wang WL, Dong JH, Li Q, Shen F, Qin SK, Fan J. Zhou J, et al. Among authors: liu rb, liu r, liu lx, liu ts. Liver Cancer. 2018 Sep;7(3):235-260. doi: 10.1159/000488035. Epub 2018 Jun 14. Liver Cancer. 2018. PMID: 30319983 Free PMC article.

8

The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study.

Cheng X, Yu S, Wang Y, Cui Y, Li W, Yu Y, Tang C, Jiang H, Ji Y, Sun Y, Wang X, Shen Z, Liu F, Liu TS. Cheng X, et al. Among authors: liu f, liu ts. Gastric Cancer. 2019 May;22(3):587-597. doi: 10.1007/s10120-018-0895-x. Epub 2018 Nov 13. Gastric Cancer. 2019. PMID: 30426294

9

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018).

Xu J, Fan J, Qin X, Cai J, Gu J, Wang S, Wang X, Zhang S, Zhang Z; China CRLM Guideline Group. Xu J, et al. J Cancer Res Clin Oncol. 2019 Mar;145(3):725-736. doi: 10.1007/s00432-018-2795-1. Epub 2018 Dec 12. J Cancer Res Clin Oncol. 2019. PMID: 30542791

10

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA).

Cui Y, Yu Y, Zheng S, Ying J, Du Y, Wang Y, Wang X, Shen Z, Liu F, Lv M, Sun Y, Liu T. Cui Y, et al. BMC Cancer. 2023 Apr 4;23(1):308. doi: 10.1186/s12885-023-10773-x. BMC Cancer. 2023. PMID: 37016303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters